 <h1>Aimovig Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>erenumab</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about erenumab. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Aimovig.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to erenumab: subcutaneous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, erenumab (the active ingredient contained in Aimovig) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking erenumab:</p><p>
<i>Less common</i>
</p><ul>
<li>Constipation</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blurred vision</li>
<li>cough</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>headache</li>
<li>hives, itching, skin rash</li>
<li>hoarseness</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness of the skin</li>
<li>slow or fast heartbeat</li>
<li>tightness in the chest</li>
<li>troubled breathing or swallowing</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of erenumab may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Muscle cramp or spasm</li>
</ul><p>
<!-- end subcutaneous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to erenumab: subcutaneous solution</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included injection site reactions and constipation.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity reactions including rash, angioedema, and anaphylaxis</p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reactions</p>
<p><b>Frequency not reported</b>: Injection site erythema, injection site pruritus, injection site pain</p><p>Injection site reactions included reports such as injection site pain and injection site erythema.  Injection site reactions were reported in 6%, 5%, and 3% of patients receiving 70 mg/month, 140 mg/month, and placebo, respectively.</p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Cramps, muscle spasms</p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Aimovig (erenumab)." Amgen USA, Thousand Oaks, CA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Emgality vs Aimovig - how do they compare?</li>
<li>How long does it take for Aimovig to start working?</li>
<li>Ajovy vs Aimovig: What's the difference between them?</li>
<li>What are the new drugs for the treatment and prevention of migraine?</li>
<li>Does Aimovig cause weight gain or loss?</li>
<li>Why does Aimovig cause constipation?</li>
<li>Can you drink alcohol with Aimovig?</li>
<li>What is the mechanism of action of Aimovig?</li>
<li>Can Aimovig cause hair loss (alopecia)?</li>
<li>How long does Aimovig last in your system?</li>
<li>What is the cost of the migraine drug Ajovy?</li>
<li>How does Aimovig work to prevent migraine?</li>
<li>How do you use the Aimovig autoinjector?</li>
<li>What type of drug is Ajovy?</li>
<li>How do you inject Aimovig?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Aimovig (erenumab)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>493 Reviews</li>
<li>Drug class: CGRP inhibitors</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Aimovig &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Migraine Prevention</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to erenumab: subcutaneous solution</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included injection site reactions and constipation.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity reactions including rash, angioedema, and anaphylaxis</p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reactions</p><p><b>Frequency not reported</b>: Injection site erythema, injection site pruritus, injection site pain</p><p>Injection site reactions included reports such as injection site pain and injection site erythema.  Injection site reactions were reported in 6%, 5%, and 3% of patients receiving 70 mg/month, 140 mg/month, and placebo, respectively.</p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Cramps, muscle spasms</p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus</p><p id="ref_1">1. "Product Information. Aimovig (erenumab)." Amgen USA, Thousand Oaks, CA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Emgality vs Aimovig - how do they compare?</li>
<li>How long does it take for Aimovig to start working?</li>
<li>Ajovy vs Aimovig: What's the difference between them?</li>
<li>What are the new drugs for the treatment and prevention of migraine?</li>
<li>Does Aimovig cause weight gain or loss?</li>
<li>Why does Aimovig cause constipation?</li>
<li>Can you drink alcohol with Aimovig?</li>
<li>What is the mechanism of action of Aimovig?</li>
<li>Can Aimovig cause hair loss (alopecia)?</li>
<li>How long does Aimovig last in your system?</li>
<li>What is the cost of the migraine drug Ajovy?</li>
<li>How does Aimovig work to prevent migraine?</li>
<li>How do you use the Aimovig autoinjector?</li>
<li>What type of drug is Ajovy?</li>
<li>How do you inject Aimovig?</li>
</ul><h2>More about Aimovig (erenumab)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>493 Reviews</li>
<li>Drug class: CGRP inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Aimovig &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Migraine Prevention</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>